Does TALIMOGENE LAHERPAREPVEC Cause Injection site pain? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Injection site pain have been filed in association with TALIMOGENE LAHERPAREPVEC (Imlygic). This represents 3.2% of all adverse event reports for TALIMOGENE LAHERPAREPVEC.
47
Reports of Injection site pain with TALIMOGENE LAHERPAREPVEC
3.2%
of all TALIMOGENE LAHERPAREPVEC reports
3
Deaths
5
Hospitalizations
How Dangerous Is Injection site pain From TALIMOGENE LAHERPAREPVEC?
Of the 47 reports, 3 (6.4%) resulted in death, 5 (10.6%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Injection site pain Listed in the Official Label?
Yes, Injection site pain is listed as a known adverse reaction in the official FDA drug label for TALIMOGENE LAHERPAREPVEC.
What Other Side Effects Does TALIMOGENE LAHERPAREPVEC Cause?
Off label use (196)
Pyrexia (135)
Product storage error (133)
Metastatic malignant melanoma (109)
Circumstance or information capable of leading to medication error (89)
Death (82)
Influenza like illness (82)
Fatigue (70)
Chills (68)
Malignant melanoma (64)
What Other Drugs Cause Injection site pain?
ADALIMUMAB (28,679)
DUPILUMAB (27,799)
ETANERCEPT (24,717)
TIRZEPATIDE (10,989)
EVOLOCUMAB (9,988)
DULAGLUTIDE (9,474)
GALCANEZUMAB-GNLM (6,622)
HUMIRA (6,005)
GLATIRAMER (5,003)
LEUPROLIDE (4,678)
Which TALIMOGENE LAHERPAREPVEC Alternatives Have Lower Injection site pain Risk?
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB-TGVS
TALIMOGENE LAHERPAREPVEC vs TAMIFLU
TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN
TALIMOGENE LAHERPAREPVEC vs TAMSULOSIN